Results 21 to 30 of about 16,979 (251)

Retrospective Analysis of Borderline Ovarian Tumors: Outcomes at a Single Center

open access: yesActa Clinica Croatica, 2019
We wanted to discuss our experiences in the approach to borderline ovarian tumors, which constitute a group different from epithelial ovarian tumors with respect to their biological structure in line with retrospective information gathered from our cases.
Ercan Yilmaz   +7 more
doaj   +1 more source

Mutations in the KRAS gene in ovarian tumors.

open access: yesFolia Histochemica et Cytobiologica, 2009
RAS genes are the most frequently mutated oncogenes detected in human cancer. In this study we analyzed the presence of mutations at codon 12 of the KRAS gene in 78 women with ovarian tumor, including 64 invasive ovarian cancers and 14 borderline ovarian
Wiesława Niklińska   +5 more
doaj   +1 more source

IMMUNOHISTOCHEMICAL EXPRESSION OF CD44V6 AND P53 STATUS IN BORDERLINE AND MALIGNANT OVARIAN SURFACE EPITHELIAL TUMORS. A CLINICO-PATHOLOGIC STUDY

open access: yesThe Iraqi Journal of Medical Sciences, 2016
Background:Ovarian epithelial cancer is a leading cause of death among gynecological malignancies due mainly to advanced stage at presentation. Objectives:To investigate the expression of CD44v6 and p53 in borderline tumors and malignant ovarian surface
Mohanad M. Abdul Ghany   +2 more
doaj   +6 more sources

Ovarian Mature Cystic Teratoma Combined with Mucinous Boderline Tumor-A Case Report with Literature Review

open access: yesBioMedica, 2020
Mature ovarian cystic teratoma with co-existing mucinous borderline tumor is an extremely rare finding in literature. Here, we report a case of bilateral mature cystic teratoma of the ovary with mucinous borderline tumors and intraepithelial carcinoma in
Lixin Wang, Gang Chen, Jingui Jiang
doaj   +3 more sources

Telomerase Expression Increased the Risk of Borderline Ovarian Tumors

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2013
Objective: To compare the expression of telomerase in benign ovarian tumors and borderline ovarian tumors. Methods: Thirteen samples of paraffin blocks of ovarian borderline tumors and benign ovarian tumors were taken from patients who underwent surgery ...
Mila Maidarti
doaj   +1 more source

Genomic aberrations in borderline ovarian tumors [PDF]

open access: yesJournal of Translational Medicine, 2010
According to the scientific literature, less than 30 borderline ovarian tumors have been karyotyped and less than 100 analyzed for genomic imbalances by CGH.We report a series of borderline ovarian tumors (n = 23) analyzed by G-banding and karyotyping as well as high resolution CGH; in addition, the tumors were analyzed for microsatellite stability ...
Micci, Francesca   +8 more
openaire   +4 more sources

Photoactivated Platinum Complexes: Targeting Membrane Proteins and Organelles for Precision Cancer Therapy

open access: yesAngewandte Chemie, EarlyView.
This review highlights an emerging anticancer approach integrating platinum agents into photodynamic therapy (PDT) and photoactivated chemotherapy (PACT) systems, further augmented by cancer cell membrane‐ and organelle‐targeting. By directing photoactivated platinum complexes from nontargeted distribution to cancer cells or defined subcellular sites ...
Shu Chen   +3 more
wiley   +2 more sources

Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal Müllerian epithelium and benign, borderline and malignant serous ovarian neoplasms

open access: yesDiagnostic Pathology, 2021
Background Aurora-A kinase is important for cellular proliferation and is implicated in the tumorigenesis of several malignancies, including of the ovary. Information regarding the expression patterns of Aurora-A in normal Müllerian epithelium as well as
Khaled J. Alkhateeb   +9 more
doaj   +1 more source

A cross-sectional study of immunohistochemical evaluation of surface epithelial ovarian tumors

open access: yesMGM Journal of Medical Sciences, 2022
Background: Ovarian cancer is one of the most common malignancies in female patients. In recent years, immunohistochemistry (IHC) has emerged as an important tool in the diagnosis of ovarian tumors.
Vikas Pandey   +2 more
doaj   +1 more source

Management of borderline ovarian tumors

open access: yesThai Journal of Obstetrics and Gynaecology, 2018
Thai Journal of Obstetrics and Gynaecology, 26, 2, 70 ...
openaire   +1 more source

Home - About - Disclaimer - Privacy